Fluorescent dye labeled influenza virus mainly infects innate immune cells and activated lymphocytes and can be used in cell-mediated immune response assay

Journal of Immunological Methods

Volumn 343, Issue 1, 2009, Pages 42-48

  Xie, Dongxu ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Cytotoxicity; Fluorescence; Granzyme B; Influenza virus; T cell

Indexed keywords

FLUORESCENT DYE; INFLUENZA VACCINE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ARTICLE; CELL KILLING; CELLULAR IMMUNITY; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; INFLUENZA VIRUS; INFLUENZA VIRUS A; INFLUENZA VIRUS B; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION;

FLOW CYTOMETRY; FLUORESCENT DYES; GRANZYMES; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA, HUMAN; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MONOCYTES; ORTHOMYXOVIRIDAE INFECTIONS; VIRUS REPLICATION;

ORTHOMYXOVIRIDAE;

EID: 60649118986     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2009.01.008     Document Type: Article

References (23)

1. Addo M.M., Altfeld M., Rosenberg E.S., Eldridge R.L., Philips M.N., Habeeb K., Khatri A., Brander C., Robbins G.K., Mazzara G.P., Goulder P.J., and Walker B.D. The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals. Proc. Natl. Acad Sci. U. S. A. 98 (2001) 1781
2. Altman J.D., Moss P.A., Goulder P.J., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., McMichael A.J., and Davis M.M. Phenotypic analysis of antigen-specific T lymphocytes. Science 274 (1996) 94
3. Betts M.R., Brenchley J.M., Price D.A., De Rosa S.C., Douek D.C., Roederer M., and Koup R.A. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281 (2003) 65
4. Doherty P.C., Turner S.J., Webby R.G., and Thomas P.G. Influenza and the challenge for immunology. Nat. Immunol. 7 (2006) 449
5. Ewen C., Kane K.P., Shostak I., Griebel P.J., Bertram E.M., Watts T.H., Bleackley R.C., and McElhaney J.E. A novel cytotoxicity assay to evaluate antigen-specific CTL responses using a colorimetric substrate for Granzyme B. J. Immunol. Methods 276 (2003) 89
6. Fields B.N. Virology vol. 1 (1996), Lippincott-Raven Publishers, Philadelphia
7. Huebner, R.C., Harmon, M.W. (1997) Influenza virus subunit conjugates In: U.S. Patent (Ed) Vol. 5,612,037. Connaught Laboratories, Inc. (Swiftwater, PA), USA.
8. Lecoeur H., Fevrier M., Garcia S., Riviere Y., and Gougeon M.L. A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity. J. Immunol. Methods 253 (2001) 177
9. Lee-MacAry A.E., Ross E.L., Davies D., Laylor R., Honeychurch J., Glennie M.J., Snary D., and Wilkinson R.W. Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide. J. Immunol. Methods 252 (2001) 83
10. Lieberman J. Tracking the killers: how should we measure CD8 T cells in HIV infection?. AIDS 18 (2004) 1489
11. Liu L., Chahroudi A., Silvestri G., Wernett M.E., Kaiser W.J., Safrit J.T., Komoriya A., Altman J.D., Packard B.Z., and Feinberg M.B. Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates. Nat. Med. 8 (2002) 185
12. Maecker H.T., Dunn H.S., Suni M.A., Khatamzas E., Pitcher C.J., Bunde T., Persaud N., Trigona W., Fu T.M., Sinclair E., Bredt B.M., McCune J.M., Maino V.C., Kern F., and Picker L.J. Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. J. Immunol. Methods 255 (2001) 27
13. McElhaney J.E., Xie D., Hager W.D., Barry M.B., Wang Y., Kleppinger A., Ewen C., Kane K.P., and Bleackley R.C. T cell responses are better correlates of vaccine protection in the elderly. J. Immunol. 176 (2006) 6333
14. Nichols J.E., Mock D.J., and Roberts Jr. N.J. Use of FITC-labeled influenza virus and flow cytometry to assess binding and internalization of virus by monocytes-macrophages and lymphocytes. Arch. Virol. 130 (1993) 441
15. Powers D.C., and Belshe R.B. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J. Infect. Dis. 167 (1993) 584
16. Rong J., Xu X., Ewen C., Bleackley R.C., and Kane K.P. Isolation and characterization of novel single-chain Fv specific for human granzyme B. Hybrid Hybridomics 23 (2004) 219
17. Rubio V., Stuge T.B., Singh N., Betts M.R., Weber J.S., Roederer M., and Lee P.P. Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat. Med. 9 (2003) 1377
18. Sun Y., Iglesias E., Samri A., Kamkamidze G., Decoville T., Carcelain G., and Autran B. A systematic comparison of methods to measure HIV-1 specific CD8 T cells. J. Immunol. Methods 272 (2003) 23
19. Thomas P.G., Keating R., Hulse-Post D.J., and Doherty P.C. Cell-mediated protection in influenza infection. Emerg. Infect. Dis. 12 (2006) 48
20. Tomaru U., Yamano Y., Nagai M., Maric D., Kaumaya P.T., Biddison W., and Jacobson S. Detection of virus-specific T cells and CD8+ T-cell epitopes by acquisition of peptide-HLA-GFP complexes: analysis of T-cell phenotype and function in chronic viral infections. Nat. Med. 9 (2003) 469
21. van Baalen C.A., Kwa D., Verschuren E.J., Reedijk M.L., Boon A.C., de Mutsert G., Rimmelzwaan G.F., Osterhaus A.D., and Gruters R.A. Fluorescent antigen-transfected target cell cytotoxic T lymphocyte assay for ex vivo detection of antigen-specific cell-mediated cytotoxicity. J. Infect. Dis. 192 (2005) 1183
22. Xie D., and McElhaney J.E. Lower GrB+ CD62Lhigh CD8 TCM effector lymphocyte response to influenza virus in older adults is associated with increased CD28null CD8 T lymphocytes. Mech. Ageing Dev. 128 (2007) 392
23. Yang O.O. Will we be able to 'spot' an effective HIV-1 vaccine?. Trends in Immunology 24 (2003) 6